{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-071385","form_type":"8-K","ticker":"TOI","cik":"0001799191","company_name":"Oncology Institute, Inc.","filed_at":"2023-06-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:40.645673+00:00","generated_at":"2026-06-14T00:27:44.419511+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Oncology Institute authorizes up to 5M share buyback at ≤$0.75; obtains lender consent","bullets":["Board approved repurchase of up to 5M shares of common stock at price not exceeding $0.75 per share.","Company entered Limited Consent with Deerfield to permit repurchases on or before June 16, 2023, at same price cap.","Repurchases may be made in open market or negotiated purchases; no obligation to repurchase any shares.","Limited Consent also waives certain notice requirements under the Facility Agreement."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-071385","json":"https://secwatch.observer/filing/0001104659-23-071385.json","markdown":"https://secwatch.observer/filing/0001104659-23-071385.md","text":"https://secwatch.observer/filing/0001104659-23-071385.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1799191/000110465923071385/0001104659-23-071385-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1799191/000110465923071385/tm2318791d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T00:27:44.419511+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}